Table 1.

Patient characteristics

CharacteristicNo. patients (N = 31)%
Median age (range), y67 (37-80)
Sex
    Male2168
    Female1032
Disease status
    Untreated1342
        De novo 516
        Secondary826
        Median age (range), y74 (51-80)
    Charlson comorbidity index
        0431
        1323
        2323
        300
        4215
        518
    Primary refractory310
        Median age (range), y60 (37-66)
    Relapsed1548
        Untreated825
        Previously treated (no. prior regimens)* 7 (1-4)23
        Median CR1 duration (range), mo4 (3-39)
        Median age (range), y65 (49-75)
Cytogenetics
    Intermediate-risk2271
    Poor-risk929
Median CD33 expression (range), %88 (36-100)
  • *Includes two patients who underwent allogeneic HSCT.